![if !IE]> <![endif]>
Nebivolol is a newer generation β-blocker with high affinity for β1-receptors. The drug is unique in its ability to cause direct vasodilation via its stimulatory effect on endothelial nitric oxide synthase. It is pres-ently available only in oral formulation; the recom-mended dose is 5–40 mg daily.
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.